| Clinical data | |
|---|---|
| Other names | CDB-4386A; 7α,11β-Dimethyl-19-nortestosterone 17β-buciclate |
| Routes of administration | Intramuscular injection |
| Drug class | Androgen;Anabolic steroid;Androgen ester;Progestogen |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C31H48O3 |
| Molar mass | 468.722 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dimethandrolone buciclate (developmental code nameCDB-4386A), ordimethandrolone bucyclate, also known as7α,11β-dimethyl-19-nortestosterone 17β-buciclate, is asyntheticanabolic–androgenic steroid (AAS) and aderivative ofnandrolone (19-nortestosterone) which was developed by the Contraceptive Development Branch (CDB) of theNational Institute of Child Health and Human Development (NICHD) and has not been marketed at this time.[1][2][3][4][5] It is anandrogen ester – specifically, the C17βbuciclate (4-butylcyclohexane-1-carboxylate)ester ofdimethandrolone, (7α,11β-dimethyl-19-nortestosterone) – and acts as aprodrug of dimethandrolone in the body.[1][2][3][4][5] Dimethandrolone buciclate is or was under investigation as a potentialmale contraceptive.[1][2][3][4][5]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |